Histologic characterization of rat vocal fold scarring

Annals of Otology, Rhinology and Laryngology

Volumn 114, Issue 3, 2005, Pages 183-191

  Tateya, Tomoko ^a   Jin, Ho Sohn ^a   Tateya, Ichiro ^a,b   Bless, Diane M ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b K4/789 CSC ^*  (United States)

Author keywords

Collagen type I; Collagen type III; Fibronectin; Hyaluronic acid; Rat model; Vocal fold scarring

Indexed keywords

ALCIAN BLUE; COLLAGEN; COLLAGEN TYPE 1; COLLAGEN TYPE 3; FIBRONECTIN; HYALURONIC ACID;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOLOGICAL MONITORING; COLLAGEN DEGRADATION; COLLAGEN SYNTHESIS; CONTROLLED STUDY; EXTRACELLULAR MATRIX; GRANULATION TISSUE; IMMUNOFLUORESCENCE; LARYNX MUCOSA; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SCAR FORMATION; STAINING; TISSUE SECTION; VOCAL CORD;

EID: 15044359071     PISSN: 00034894     EISSN: None     Source Type: Journal    
DOI: 10.1177/000348940511400303     Document Type: Article

References (25)

1. Gray SD, Titze IR, Chan R, Hammond TH. Vocal fold proteoglycans and their influence on biomechanics. Laryngoscope 1999;109:845-54.
2. Gray SD, Titze IR, Alipour F, Hammond TH. Biomechanical and histologic observations of vocal fold fibrous proteins. Ann Otol Rhinol Laryngol 2000;109:77-85.
3. Benninger MS, Alessi D, Archer S, et al. Vocal fold scarring: current concepts and management. Otolaryngol Head Neck Surg 1996;115:474-82.
4. Rousseau B, Hirano S, Scheidt TD, et al. Characterization of vocal fold scarring in a canine model. Laryngoscope 2003;113:620-7.
5. Hirano S, Bless DM, Rousseau B, Welham N, Scheidt T, Ford CN. Fibronectin and adhesion molecules on canine scarred vocal folds. Laryngoscope 2003;113:966-72.
6. Thibeault SL, Gray SD, Bless DM, Chan RW, Ford CN. Histologic and rheologic characterization of vocal fold scarring. J Voice 2002;16:96-104.
7. Kurita S, Nagata K, Hirano M. A comparative study of the layer structure of the vocal fold. In: Bless DM, Abbs JH, eds. Vocal fold physiology: contemporary research and clinical issues. San Diego, Calif: College-Hill Press, 1983:3-21.
8. Rousseau B, Hirano S, Chan RW, et al. Characterization of chronic vocal fold scarring in a rabbit model. J Voice 2004;18:116-24.
9. Hammond TH, Zhou R, Hammond EH, Pawlak A, Gray SD. The intermediate layer: a morphologic study of the elastin and hyaluronic acid constituents of normal human vocal folds. J Voice 1997;11:59-66.
10. Chan RW, Gray SD, Titze IR. The importance of hyaluronic acid in vocal fold biomechanics. Otolaryngol Head Neck Surg 2001;124:607-14.
11. Stephens P, Thomas DW. The cellular proliferative phase of the wound repair process. J Wound Care 2002;11:253-61.
12. Peled ZM, Chin GS, Liu W, Galliano R, Longaker MT. Response to tissue injury. Clin Plast Surg 2000;27:489-500.
13. Ruoslahti E. Fibronectin and its receptors. Annu Rev Biochem 1988;57:375-413.
14. Inagi K, Connor NP, Ford CN, et al. Physiologic assessment of botulinum toxin effects in the rat larynx. Laryngoscope 1998;108:1048-54.
15. Suzuki T, Connor NP, Lee K, Leverson G, Ford CN. Laryngeal-respiratory kinematics are impaired in aged rats. Ann Otol Rhinol Laryngol 2002;111:684-9.
16. Lawrence WT. Wound healing biology and its application to wound management. In: O'Leary JP, ed. The physiologic basis of surgery. 2nd ed. Baltimore, Md: Williams & Wilkins, 1996:118-40.
17. Ehrlich HP. Collagen considerations in scarring and regenerative repair. In: Garg HG, Longaker MT, eds. Scarless wound healing. New York, NY: Marcel Dekker, 2000:99-113.
18. Cornelissen AM, Maltha JC, Von den Hoff JW, Kuijpers-Jagtman AM. Local injection of IFN-gamma reduces the number of myofibroblasts and the collagen content in palatal wounds. J Dent Res 2000;79:1782-8.
19. Gray SD, Hirano M, Sato K. Molecular and cellular structure of vocal fold tissue. In: Titze IR, ed. Vocal fold physiology: frontiers of basic science. San Diego, Calif: Singular Publishing Group, 1993:1-34.
20. Brown LF, Dubin D, Lavigne L, Logan B, Dvorak HF, Van de Water L. Macrophages and fibroblasts express embryonic fibronectins during cutaneous wound healing. Am J Pathol 1993;142:793-801.
21. Courey MS, Shohet JA, Scott MA, Ossoff RH. Immunohistochemical characterization of benign laryngeal lesions. Ann Otol Rhinol Laryngol 1996;105:525-31.
22. Hirano S, Bless DM, Heisey D, Ford CN. Effect of growth factors on hyaluronan production by canine vocal fold fibroblasts. Ann Otol Rhinol Laryngol 2003;112:617-24.
23. Hallen L, Dahlqvist A, Laurent C. Dextranomeres in hyaluronan (DiHA): a promising substance in treating vocal cord insufficiency. Laryngoscope 1998;108:393-7.
24. Hallen L, Testad P, Sederholm E, Dahlqvist A, Laurent C. DiHA (dextranomers in hyaluronan) injections for treatment of insufficient closure of the vocal folds: early clinical experiences. Laryngoscope 2001;111:1063-7.
25. Hertegard S, Hallen L, Laurent C, et al. Cross-linked hyaluronan used as augmentation substance for treatment of glottal insufficiency: safety aspects and vocal fold function. Laryngoscope 2002;112:2211-9.